Cannara Biotech
TSX:LOVE
C$ 1,82
C$-0,02 (-1,09%)
1,82 C$
C$-0,02 (-1,09%)
End-of-day quote: 04/24/2026

Cannara Biotech Stock Value

Analysts currently give TSX:LOVE a rating of Buy.
Buy
Buy

Cannara Biotech Company Info

EPS Growth 3Y
100,00%
Market Cap
C$0,18 B
Long-Term Debt
C$0,03 B
Short Interest
0,39%
Quarterly earnings
04/14/2026
Dividend
C$0,00
Dividend Yield
0,00%
Founded
2017
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

C$3,13
71.98%
71.98
Last Update: 04/24/2026
Analysts: 4

Highest Price Target C$3,50

Average Price Target C$3,13

Lowest Price Target C$3,00

In the last five quarters, Cannara Biotech’s Price Target has risen from C$0,00 to C$1,82 - a 100,00% increase. Two analysts predict that Cannara Biotech’s share price will increase in the coming year, reaching C$3,13. This would represent an increase of 71,98%.

Top growth stocks in the health care sector (5Y.)

What does Cannara Biotech do?

Cannara Biotech Inc. is a Canadian company primarily involved in the cultivation, production, and distribution of cannabis products. The company operates through state-of-the-art facilities that enhance its ability to deliver premium quality cannabis to the market. The company focuses on various aspects of the cannabis industry, including processing, branding, and retail sales, adapting to evolving regulations and market demands. The company is committed to high standards of safety and quality...
×